Latvija - latvijski - Zāļu valsts aģentūra

boehringer ingelheim international gmbh, germany - tiotropijs - inhalācijas pulveris, cietā kapsula - 18 μg

Latvija - latvijski - Zāļu valsts aģentūra

boehringer ingelheim international gmbh, germany - tiotropijs - inhalācijas pulveris, cietā kapsula - 18 μg

Europska Unija - latvijski - EMA (European Medicines Agency)

astrazeneca ab - durvalumab - karcinoma, nesīkšūnu plaušas - antineoplastiski līdzekļi - non-small cell lung cancer (nsclc)imfinzi as monotherapy is indicated for the treatment of locally advanced, unresectable non small cell lung cancer (nsclc) in adults whose tumours express pd-l1 on ≥ 1% of tumour cells and whose disease has not progressed following platinum based chemoradiation therapy (see section 5. imfinzi in combination with tremelimumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic nsclc with no sensitising egfr mutations or alk positive mutations. small cell lung cancer (sclc)imfinzi in combination with etoposide and either carboplatin or cisplatin is indicated for the first-line treatment of adults with extensive-stage small cell lung cancer (es-sclc). biliary tract cancer (btc)imfinzi in combination with gemcitabine and cisplatin is indicated for the first line treatment of adults with unresectable or metastatic biliary tract cancer (btc). hepatocellular carcinoma (hcc)imfinzi in combination with tremelimumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc).

Europska Unija - latvijski - EMA (European Medicines Agency)

rad neurim pharmaceuticals eec sarl - melatonin - sleep initiation and maintenance disorders; autistic disorder - psihoterapija - slenyto ir indicēts, lai ārstētu bezmiegs bērniem un pusaudžiem vecumā 2-18. daļa ar autismu spektra traucējumi (asd) un / vai smits-magenis sindroms, kur gulēt higiēnas pasākumi nav bijuši pietiekami,.

Europska Unija - latvijski - EMA (European Medicines Agency)

glaxosmithkline biologicals sa - recombinant varicella zoster virus glycoprotein e - herpes zoster - vakcīnas - shingrix is indicated for prevention of herpes zoster (hz) and post-herpetic neuralgia (phn), in:adults 50 years of age or older;adults 18 years of age or older at increased risk of hz. izmantot shingrix būtu saskaņā ar oficiālās rekomendācijas.

Latvija - latvijski - Pārtikas un veterinārais dienests, Zemkopības ministrija

ražots eiropas savienībā - šķidrums

Latvija - latvijski - Pārtikas un veterinārais dienests, Zemkopības ministrija

tibetan healing center, sia - pulveris

Latvija - latvijski - Pārtikas un veterinārais dienests, Zemkopības ministrija

aloe vera of america inc. - tablete

Latvija - latvijski - Pārtikas un veterinārais dienests, Zemkopības ministrija

alfa omega s.r.l. - šķidrums

Latvija - latvijski - Pārtikas un veterinārais dienests, Zemkopības ministrija

mk narodnaja medicina - cits, droga